
Home Questions About Raises, Shuttle Fees Top Administrators Forum A UAMS Update article about Meet Your Administrator” Gruenwald Is New U.S. Citizen Michael Gruenwald becomes U.S. citizen Gruenwald Is New U.S. Citizen Michael Gruenwald becomes U.S. citizen Doughnut Sale to Help UAMS Psychiatry Youth Program A UAMS Update article about a bake sale Call-in Announcements, Forums Will Give Employees More Information A UAMS Update article about plans to improve communication between administration and employees of UAMS Medical Center IT Help Desk 400,000th Call Sweepstakes IT Help Desk 400,000th Call Sweepstates The UAMS Help Desk Today - Ten Years Later The UAMS Help Desk Today - Ten Years Later Free Tickets for UAMS Nights at Ray Winder Field A UAMS Update article about UAMS Night with the Travelers ARIA Training Sessions May 19 - June 27 at UAMS A UAMS Update article about May 19 - June 27 training sessions Human Research Forum Is May 21 A UAMS Update article about human research Q & A Accolades, May 2003 Accolades to UAMS faculty and staff GCRC Deadline Changed to July 1 for Grant Proposals A UAMS Update article about GCRC pilot grants History of the Help Desk Watch, Look & Listen: Preview of New UAMS Public Service Campaign Forum to Discuss Impact of HIPAA on Research Update article about HIPAA and research at UAMS Human Research Q and A Forum June 27 A UAMS Update article about the human research forum Emailed Version of UAMS Notice of Privacy Practices UAMS Notice of Privacy Practices Free UAF Symposium Aug. 14-15 on Evolution of Human Diet A UAMS Update article about a diet symposium at UAF Tom Butler is Arkansas Administrator of the Year Tom Butler of UAMS Is Arkansas Administrator of the Year Join the Prostate Cancer Race Walk. Click Here for Registration Form.* Join the Prostate Cancer Race Walk. Click Here for Registration Form. Join the Prostate Cancer Race Walk. Click Here for Registration Form.* Join the Prostate Cancer Race Walk. Click Here for Registration Form. Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS Defense Department Funds Possible Therapeutic Vaccine for Ovarian Cancer at UAMS Join UAMS/ACRC Team in Race for the Cure®! Join UAMS/ACRC Team in Race for the Cure! Join UAMS/ACRC Team in Race for the Cure®! Join UAMS/ACRC Team in Race for the Cure! UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test UAMS Scientist Receives $272,000 Grant for Tailoring Cancer Treatments with Laser Test Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion Photo Album: Stephens Institute Was a Highlight of Medicine Alumni Reunion Kids First in Fort Smith Celebrated Fourth in Style Kids First in Fort Smith Celebrated Fourth in Style Class of 1948 Dedicates Endowment to Excellence in Education Class of 1948 Dedicates Endowment to Excellence in Education Pharmacy Professor Elected to American College of Clinical Pharmacy Pharmacy Professor Elected to American College of Clinical Pharmacy Pharmaceutical Scientists, Graduate Students Meet at UAMS Pharmaceutical Scientists, Graduate Students Meet at UAMS Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy Stephanie Gardner, Pharm.D., Ed.D., Is Interim Dean of College of Pharmacy New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health New COPH Survey Research Expert Eager to Develop New Ways of Measuring Public Health Ready, Set, Go! UAMS, KATV Launch Get Healthy Arkansas™ UAMS, KATV Launch Get Healthy Arkansas™ Friends of Psychiatry Start Research Fund Friends of Psychiatry launch endowment campaign for research UAMS Receives $1.3 Million in Research Funds UAMS receives $1.3 mil for research projects UAMS Receives $1.3 Million in Research Funds UAMS receives $1.3 mil for research projects UAMS Receives $89,000 in Research Funds for Cancer Information Service at ACRC UAMS receives $89K grant from NCI for Cancer Information Service project UAMS Receives $89,000 in Research Funds for Cancer Information Service at ACRC UAMS receives $89K grant from NCI for Cancer Information Service project UAMS Receives $89,000 in Research Funds for Cancer Information Service at ACRC UAMS receives $89K grant from NCI for Cancer Information Service project UAMS Receives $568,000 in Research Funds UAMS receives $568K in reserach funds during week of Feb. 5, 2001 UAMS Receives $568,000 in Research Funds UAMS receives $568K in reserach funds during week of Feb. 5, 2001 UAMS Receives $2.3 Million for Research Projects UAMS receives $2.3 mil for research projects during week of Jan. 22, 2001 UAMS Receives $2.3 Million for Research Projects UAMS receives $2.3 mil for research projects during week of Jan. 22, 2001 UAMS Receives $503,000 in Research Funds UAMS receives $503K for research UAMS Receives $503,000 in Research Funds UAMS receives $503K for research UAMS Receives $959,000 in Research Funds UAMS receives $959K in research funds during week of March 5, 2001 UAMS Receives $959,000 in Research Funds UAMS receives $959K in research funds during week of March 5, 2001 UAMS Researcher Reports Breakthrough toward Cure for Osteoporosis Manolagas reports breakthrough in path to new treatment for osteoporosis UAMS Researcher Reports Breakthrough toward Cure for Osteoporosis Manolagas reports breakthrough in path to new treatment for osteoporosis UAMS Researcher Reports Breakthrough toward Cure for Osteoporosis Manolagas reports breakthrough in path to new treatment for osteoporosis Medical Research Endowment Grant Funds Available MRE grants of about $100K available to UAMS research scientists Medical Research Endowment Grant Funds Available MRE grants of about $100K available to UAMS research scientists UAMS Receives $642,000 in Research Grants UAMS receives $642K in research grants during week of Feb. 20, 2001 UAMS Receives $642,000 in Research Grants UAMS receives $642K in research grants during week of Feb. 20, 2001 UAMS Receives $1,609,000 in Research Funds UAMS receives $1.6 mil in research funds during week of April 9, 2001 UAMS Receives $1,609,000 in Research Funds UAMS receives $1.6 mil in research funds during week of April 9, 2001 UAMS Researcher Receives License Funds from Celgene Researcher receives license check from Celgene for patented colorectal treatment UAMS Researcher Receives License Funds from Celgene Researcher receives license check from Celgene for patented colorectal treatment UAMS Researcher Receives License Funds from Celgene Researcher receives license check from Celgene for patented colorectal treatment UAMS Researcher Receives License Funds from Celgene Researcher receives license check from Celgene for patented colorectal treatment Current Research at UAMS Is Now Online Report of current research at UAMS Researcher Briefs UAMS Consortium Members on Alzheimer's Disease Griffin presents research on Alzheimer's Disease to UAMS Consortium Researcher Briefs UAMS Consortium Members on Alzheimer's Disease Griffin presents research on Alzheimer's Disease to UAMS Consortium Researcher Briefs UAMS Consortium Members on Alzheimer's Disease Griffin presents research on Alzheimer's Disease to UAMS Consortium UAMS Receives $1,683,000 for Research UAMS receives $1.683 mil for research UAMS Receives $1,683,000 for Research UAMS receives $1.683 mil for research UAMS Receives $544,000 in Research Funds UAMS receives $544K in research funds UAMS Receives $544,000 in Research Funds UAMS receives $544K in research funds UAMS Receives $715,000 In Research Funds UAMS receives $715K in research funds UAMS Receives $715,000 In Research Funds UAMS receives $715K in research funds Nursing Researcher Selected for New York Seminar Pao-Feng Tsai, Ph.D., RN, selected to present research at seminar in NYC Nursing Researcher Selected for New York Seminar Pao-Feng Tsai, Ph.D., RN, selected to present research at seminar in NYC Cellular and Molecular Research: An Exciting Time To Be a Scientist (video) UAMS and two partner campuses have received a $6 million grant for a complex project to link biomedical researchers around Arkansas. Cellular and Molecular Research: An Exciting Time To Be a Scientist (video) UAMS and two partner campuses have received a $6 million grant for a complex project to link biomedical researchers around Arkansas. UAMS, Partners Receive $6 Million for Biomedical Research Network UAMS and two partner campuses have received a $6 million, three-year grant to create a network of high-powered research laboratories and expand Arkansas’s biotechnology workforce. UAMS, Partners Receive $6 Million for Biomedical Research Network UAMS and two partner campuses have received a $6 million, three-year grant to create a network of high-powered research laboratories and expand Arkansas’s biotechnology workforce. UAMS to Create Myeloma Institute UAMS announces Myeloma Institute for Research and Therapy UAMS to Create Myeloma Institute UAMS announces Myeloma Institute for Research and Therapy UAMS to Create Myeloma Institute UAMS announces Myeloma Institute for Research and Therapy UAMS Receives $834,500 in Research Funds UAMS receives $834.5K for medical research UAMS Receives $834,500 in Research Funds UAMS receives $834.5K for medical research UAMS Creates Myeloma Institute (audio bites) UAMS establishes Myeloma Institute for Research and Therapy UAMS Creates Myeloma Institute (audio bites) UAMS establishes Myeloma Institute for Research and Therapy UAMS Cardiologist To Appear on KATV Saucedo scheduled to appear on TV/7 to discuss his cardiac research findings. UAMS Cardiologist To Appear on KATV Saucedo scheduled to appear on TV/7 to discuss his cardiac research findings. G. Richard Smith, M.D., Is New Chair of Psychiatry Smith appointed chair of Department of Psychiatry and Behavioral Sciences. G. Richard Smith, M.D., Is New Chair of Psychiatry Smith appointed chair of Department of Psychiatry and Behavioral Sciences. G. Richard Smith, M.D., Is New Chair of Psychiatry Smith appointed chair of Department of Psychiatry and Behavioral Sciences. G. Richard Smith, M.D., Is New Chair of Psychiatry Smith appointed chair of Department of Psychiatry and Behavioral Sciences. Students Are Partners in Research Medical, pharmacy, and undergraduate students presented their research findings at a scientific symposium at UAMS campus. Students Are Partners in Research Medical, pharmacy, and undergraduate students presented their research findings at a scientific symposium at UAMS campus. UAMS Receives $6,066,000 in Research Funding Researchers at UAMS received approximately $6 million in research funding during the weeks of Aug. 27 – Sept. 14, 2001. UAMS Receives $6,066,000 in Research Funding Researchers at UAMS received approximately $6 million in research funding during the weeks of Aug. 27 – Sept. 14, 2001. UAMS Researcher Wins Heart Association Award Kennedy receives Worthen-Cornett Award from American Heart Association. UAMS Researcher Wins Heart Association Award Kennedy receives Worthen-Cornett Award from American Heart Association. Donations Fund New Research Grants The UAMS Foundation Fund Board has awarded nine internal research grants to faculty scientists; the allocations come from income from the UAMS Medical Research Endowment Fund. Donations Fund New Research Grants The UAMS Foundation Fund Board has awarded nine internal research grants to faculty scientists; the allocations come from income from the UAMS Medical Research Endowment Fund. Clinical Research Grant Deadline Is Dec. 1, 2001 The first deadline is December 1, 2001 in a new grant program at UAMS. Clinical Research Grant Deadline Is Dec. 1, 2001 The first deadline is December 1, 2001 in a new grant program at UAMS. Cell Biology Society Selects UAMS Researcher for Prestigious Publication The American Society for Cell Biology has included the recent work of Cynthia J.M. Kane, Ph.D., of UAMS in its Press Book 2001 - a summary of important new research in cell biology. Cell Biology Society Selects UAMS Researcher for Prestigious Publication The American Society for Cell Biology has included the recent work of Cynthia J.M. Kane, Ph.D., of UAMS in its Press Book 2001 - a summary of important new research in cell biology. UAMS Scientists Study Acetaminophen Overdoses Scientists at UAMS are studying why acetaminophen, an ingredient in many non-prescription medicines for pain and fever, can cause liver damage if given in large doses. UAMS Scientists Study Acetaminophen Overdoses Scientists at UAMS are studying why acetaminophen, an ingredient in many non-prescription medicines for pain and fever, can cause liver damage if given in large doses. Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09) Novel biomarker profile for the management of metastisis to bone of patients with breast cancer. Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09) Novel biomarker profile for the management of metastisis to bone of patients with breast cancer. Novel plasma biomarker and marker profiles for analysis of metastatic disease: A unique fragment of parathyroid hormone related protein predicts breast metastasis to bone (11-09) Novel biomarker profile for the management of metastisis to bone of patients with breast cancer. Gray’s Anomaly: A Source of Empowerment Feb. 8, 2012 \| “I’ll trim it so it’s not so bulky,” James Y. Suen, M.D., said as he folded, then snipped a tiny edge of gauze off before he placed it on his patient’s right jaw. He has cared for 23-year-old Jasmine Gray ever since she was 11 when she traveled from Memphis, Tenn. to see him after first being misdiagnosed. Need Something Sweet for Your Valentine? Need Something Sweet for Your Valentine? Need Something Sweet for Your Valentine? Need Something Sweet for Your Valentine? Code Moo Now Open Code Moo Now Open Code Moo Now Open Code Moo Now Open Sign Up for the UAMS House of Delegates Relay for Life Team UAMS House of Delegates Relay for Life Team Sign Up for the UAMS House of Delegates Relay for Life Team UAMS House of Delegates Relay for Life Team Overwhelming Response to SmartCare Overwhelming Response to SmartCare Overwhelming Response to SmartCare Overwhelming Response to SmartCare Celebrating African American Women Firsts Celebrating African American Women Firsts Celebrating African American Women Firsts Celebrating African American Women Firsts Nutrition Department Hosts Food Drive Nutrition Department Hosts Food Drive Nutrition Department Hosts Food Drive Nutrition Department Hosts Food Drive In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11 Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11 Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. 11-11 Treatment of cardiovascular diseases, heart attack and stroke remain leading causes of death in the world, affecting close to 15 million individuals per year. Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) The present invention is a method of in vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. The Photo Acoustic technique based on detection of laser−induced acoustic waves provides greater sensitivity and spatial resolution in deeper tissue compared to the other optical modalities. In vivo multicolor flow cytometry, negative and positive PA contrasts integrated with focused ultrasound has potential for dynamic study of various clots directly in the bloodstream of superficial microvessels associated with different diseases (e.g., cardiovascular disorder, cancer metastasis, or infection) and their treatment (e.g., stents, implants, drugs) which otherwise could not be detected with existing techniques. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks. In vivo flow cytometry with negative photo acoustic contrast for noninvasive, continuous, real−time detection of circulating clots. (11-11) Among various risk factors, circulating clots (termed also thrombi) may cause unexpected death or stoke. At present no clinically relevant method has been developed for early detection of circulating clots despite their clinical significance as prognostic markers for preventing stroke and heart attacks.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software